Allergens are widespread, but highly variable in U.S. homes, according to the nation’s largest indoor allergen study to date. Researchers from the National Institutes of Health on Thursday reported that more than 90% of homes had three or more detectable allergens, and 73% of homes had at least one allergen at elevated levels.
Earlier this month Innovus Pharmaceuticals launched FlutiCare OTC in the U.S., making it the third branded fluticasone propionate nasal spray on the market. Innovus, based in San Diego, secured distribution through more than 10,000 independent pharmacies through AmerisourceBergen and McKesson and Walmart online.
As a second phase of its launch, Innovus Pharma will launch FlutiCare to large retail stores.
LONDON — If Pfizer follows through with its announcement last week to potentially place its consumer business up for sale, GlaxoSmithKline, presently the third-largest OTC seller in the U.S. marketplace, would certainly take a look at it, the company's CEO shared Wednesday morning.